The Global Preclinical Antibacterial Pipeline - Editors in Conversation

The Global Preclinical Antibacterial Pipeline - Editors in Conversation

American Society for Microbiology via YouTube Direct link

CDC vs WHO

4 of 18

4 of 18

CDC vs WHO

Class Central Classrooms beta

YouTube videos curated by Class Central.

Classroom Contents

The Global Preclinical Antibacterial Pipeline - Editors in Conversation

Automatically move to the next video in the Classroom when playback concludes

  1. 1 Introduction
  2. 2 Bacterial Priority Pathogen List
  3. 3 Research and Targeting
  4. 4 CDC vs WHO
  5. 5 WHO fungal pathogen priority list
  6. 6 Methodology
  7. 7 Innovation
  8. 8 Innovation vs Inhibitors
  9. 9 Size of antibacterial research programs
  10. 10 High failure rate of antibacterial compounds
  11. 11 Lack of interest and investment
  12. 12 Pipeline composition
  13. 13 INDEnabling Phase
  14. 14 Mechanism of Action
  15. 15 Narrow Spectrum
  16. 16 Preclinic Programs
  17. 17 Limitations
  18. 18 Future

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Someone learning on their laptop while sitting on the floor.